Company page

Maxcyte, Inc.

Maxcyte, Inc. is a public company traded on the American stock market under the ticker MXCT. The company has a market capitalization of approximately $132.83 million. Maxcyte focuses on providing cell-engineering technology and services to support the development of advanced therapies.